Grants per year
Personal profile
Research Interests
Dr. Cohn is an expert in HIV medicine, infectious disease, HIV clinical trials and health services outcomes research. She has been an active participant in the NIH/NIAID AIDS Clinical Trials Group since 1988, and has held numerous leadership positions including Vice Chair and Chair of the Women’s Health Committee and the Outcomes Committee, Vice-Chair of the Underrepresented Populations Committee 2008-2010 and Chair of the Women’s Health Internetwork Scientific Committee (WHISC). She is chair and vice-chair of major protocols pertaining to women's health, self-management and outcomes, recruitment of women and minorities into clinical trials, and optimizing ART, and is an active team member on many other protocols. Her current research areas have included optimizing the health of HIV-infected women, improving adherence to antiretrovirals, and improving access to health care and clinical trials for underrepresented populations. Dr. Cohn has maintained an active HIV clinical practice, has been a teacher of HIV medicine to medical students, residents, fellows, nurses and other care professors for over 25 years. She has mentored nurses, nurse practitioners, physician assistants, residents, and other faculty both in and out of her institution, helping to advance their careers in both research and clinical medicine. Dr. Cohn is the past Chair of Northwestern Medical Women Faculty Organization (WFO) which is committed to advancing the careers of women faculty members at all levels within Feinberg School of Medicine.
Certifications and Licenses
Internal Medicine | |
Infectious Disease |
Training Experience
1987 | Residency, Boston City Hospital |
1991 | Fellowship, University of North Carolina Hospitals |
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
MPH, University of North Carolina
… → 1992
MD, Medicine, Cornell University Medical College
… → 1984
Research interests keywords
- AIDS
- HIV Infection
- Health Services Research
- Infectious Diseases: Viral
- Women's Health / Women's Reproductive Health
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Chicago Clinical Trials Unit
Taiwo, B. O., Achenbach, C. J., Cohn, S. E., Feinstein, M. J., Galvin, S. R., Green, R., Hawkins, C. A., Maiga, M., Masters, M. C., Murphy, R. L. & Palella Jr, F. J.
National Institute of Allergy and Infectious Diseases
12/1/20 → 11/30/27
Project: Research project
-
Chicago Clinical Trials Unit
Taiwo, B. O., Achenbach, C. J., Cohn, S. E., Feinstein, M. J., Galvin, S. R., Green, R., Hawkins, C. A., Maiga, M., Masters, M. C., Murphy, R. L., Palella Jr, F. J. & Cohn, S. E.
National Institute of Allergy and Infectious Diseases
12/1/20 → 11/30/27
Project: Research project
-
ACTG A5392 Protocol Chair Support
University of California at Los Angeles, National Institute of Allergy and Infectious Diseases
12/1/19 → 11/30/20
Project: Research project
-
Effect of double-dose levonorgestrel subdermal implant in women taking efavirenz-based antiretroviral therapy: The DoubLNG pharmacokinetic study
Cirrincione, L. R., Nakalema, S., Chappell, C. A., Byakika-Kibwika, P., Kyohairwe, I., Winchester, L., Mackline, H., Pham, M. M., Cohn, S. E., Siccardi, M., Owen, A., Fletcher, C. V., Lamorde, M. & Scarsi, K. K., Jun 2023, In: Contraception. 122, 109975.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Pharmacogenetic interactions of efavirenz or rifampin and isoniazid with levonorgestrel emergency contraception during treatment of HIV or tuberculosis
Agyemang, N., Scarsi, K. K., Baker, P., Smeaton, L. M., Podany, A. T., Olefsky, M., Woolley, E., Barr, E., Pham, M., Mawlana, S., Supparatpinyo, K., Gatechompol, S., Jalil, E. M., Gadama, L., Badal-Faesen, S., Van Schalkwyk, M., Kayama, C., Belaunzaran-Zamudio, P. F., Godfrey, C., Cohn, S. E., & 2 others , Aug 1 2023, In: Pharmacogenetics and genomics. 33, 6, p. 126-135 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Pharmacokinetics of dose-adjusted levonorgestrel emergency contraception combined with efavirenz-based antiretroviral therapy or rifampicin-containing tuberculosis regimens
AIDS Clinical Trials Group A5375 Study Team, May 2023, In: Contraception. 121, 109951.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
A Community Call to Action to Prioritize Inclusion and Enrollment of Women in HIV Cure-related Research
Campbell, D. M., Cowlings, P. D., Tholanah, M., Robinson, M. J., Graham, G., Aseru, S., Dubé, K., Cohn, S. E., Bar, K. J., Connick, E., Mngqbisa, R., Scully, E. P., Stockman, J. K. & Gianella, S., Dec 15 2022, In: Journal of Acquired Immune Deficiency Syndromes. 91, 5, p. E12-E14Research output: Contribution to journal › Letter › peer-review
Open Access1 Scopus citations -
Pharmacogenetics of interaction between depot medroxyprogesterone acetate and efavirenz, rifampicin, and isoniazid during treatment of HIV and tuberculosis
Haas, D. W., Mngqibisa, R., Francis, J., McIlleron, H., Robinson, J. A., Kendall, M. A., Baker, P., Mawlana, S., Badal-Faesen, S., Angira, F., Omoz-Oarhe, A., Samaneka, W. P., Denti, P. & Cohn, S. E., Jan 1 2022, In: Pharmacogenetics and genomics. 32, 1, p. 24-30 7 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations